Physician profile
Annapoorna S Kini
NPI 1952343212
$176,049.41
in general payments reported to CMS, 2019-2025
17 companies · $39K in 2025
The $39K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,369 · 2020: $66K · 2021: $2,048 · 2022: $8,280 · 2023: $30K · 2024: $23K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $75K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Consulting Fee: $2,200 · Food and Beverage: $2,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $75,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,000.00 |
| Consulting Fee | $2,200.00 |
| Food and Beverage | $2,105.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $135,000.00 | 2020-2025 | General - Atherectomy, General - Catheter |
| Medtronic, INC. | $22,163.51 | 2021-2024 | Symplicity G3 |
| Medtronic Vascular, INC. | $14,043.63 | 2019-2020 | |
| Shockwave Medical, INC | $2,457.38 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $1,725.14 | 2019-2025 | Navitor, Mitraclip, Perclose Prostyle |
| Edwards Lifesciences Corporation | $252.24 | 2022-2024 | Pascal, Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $112.64 | 2024-2025 | |
| Cordis US Corp. | $69.75 | 2021-2022 | |
| Cardiva Medical, INC. | $46.55 | 2023-2025 | Savvywire, Cardiva Vascade 6/7f Vcs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.46 | 2019 | |
| Abiomed | $27.59 | 2019 | |
| Penumbra, INC. | $25.65 | 2020 | |
| Cook Medical LLC | $25.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $21.14 | 2020 | |
| Teleflex LLC | $17.89 | 2023 | Turnpike |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.84 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annapoorna Kini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.